Phase 3 Readout
IPIX: Phase 3 Topline: A Phase III, Randomized, Double-blind, Multiple Doses, Placebo-controlled, Parallel-group Adaptive S
December 31, 2027. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- December 31, 2027
- Company
- Innovation Pharmaceuticals Inc. (IPIX)
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 3 Readout~month
Phase 3 Topline: A Phase III, Randomized, Double-blind, Multiple Doses, Placebo-controlled, Parallel-group Adaptive S
- Indication
- Myopia